Where does Bayer Pharma Aktiengesellschaft rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bayer Pharma Aktiengesellschaft ranks #1,295 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bayer Pharma Aktiengesellschaft hold?

Bayer Pharma Aktiengesellschaft holds 326 US utility patents granted between 2015 and 2025, spanning 33 technology areas.

What is Bayer Pharma Aktiengesellschaft's Innovation Score?

Bayer Pharma Aktiengesellschaft has an Innovation Score of 53.6 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Bayer Pharma Aktiengesellschaft's patent grant rate increasing or decreasing?

Bayer Pharma Aktiengesellschaft's recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bayer Pharma Aktiengesellschaft's patents?

Bayer Pharma Aktiengesellschaft's patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bayer Pharma Aktiengesellschaft patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bayer Pharma Aktiengesellschaft

Q: What technology areas does Bayer Pharma Aktiengesellschaft focus on?

Bayer Pharma Aktiengesellschaft's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 289 patents. Grants appear in 33 CPC subclasses total.

USPTO PatentsView assignee record - 326 granted patents across 33 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bayer ranks #1,295 of 49,997 tracked US assignees by granted-patent volume, with 326 patents across 33 technology areas.

#1,295
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.6/100): 14.9
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1295 · Foreign Corporation #1,295 · 326 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 326 grants
TOP-DECILE #1,295/49,997
PHOTO-FINISH Hangzhou Hikvision…
CPC-FOCUS A61P · 33 areas
INNOV-PAR 53.6/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hangzhou Hikvision Digital Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Advanced Micro-fabri… · near

54
Bayer Pharma… · this assignee

54
Halozyme · near

54
Heatcraft Refrigerat… · near

54
Oxylabs UAB · near

54
3D Lighting… · lowest

7

What this shows Bayer's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Bayer's grants concentrate

Bayer Pharma Aktiengesellschaft is a focused PatentsView assignee: 33 CPC subclasses with 88.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (49 grants) versus a trough of 5 in 2015. By volume, Bayer sits between Alpha and Omega Semiconductor, Ltd. and Ningde Amperex Technology Limited.

Bayer's three-year grant acceleration

From 2019–2021 to 2022–2024, Bayer Pharma Aktiengesellschaft moved from 116 to 75 grants (0.65x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,317. See the growth leaderboard.

Alpha and Omega S…

327
Brother Industries

327
Medimmune

327
University of Hou…

327
Hangzhou Hikvisio…

326
Klemm + Sohn & KG

326
Littelfuse

326
Ningde Amperex Te…

326
Bayer Pharma Akti… ◀

326

What this shows Bayer holds 326 patents at rank #1,295, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bayer

By rank, the assignees closest to #1,295 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Bayer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bayer, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Heatcraft Refrigeration Products LLC 54 Halozyme, Inc. 54 Oxylabs, UAB 54 Advanced Micro-fabrication Equipment Inc. China 54

Similar claim depth

Nearest assignees by average claims per patent (14.9 here).

Consejo Superior de Investigaciones Cientificas (CSIC) 14.9 avg Wiwynn Corporation 14.9 avg Conversant Wireless Licensing S.à r.l. 14.9 avg Hisense USA Corporation 14.9 avg

Bayer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bayer Pharma Aktiengesellschaft patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	1.5%
2016	32	9.8%
2017	47	14.4%
2018	44	13.5%
2019	49	15.0%
2020	30	9.2%
2021	37	11.3%
2022	33	10.1%
2023	22	6.7%
2024	20	6.1%
2025partial year	7	2.1%

Which technologies does Bayer Pharma Aktiengesellschaft patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 289

C07D - Heterocyclic Compounds 246

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 245

C07K - Peptides 23

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 16

C07C - Acyclic OR Carbocyclic Compounds 15

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 14

Y02A - Technologies FOR Adaptation TO Climate Change 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C07J - Steroids 6

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61B - DIAGNOSIS; SURGERY; Identification 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

Top 15 of 33 technology areas

Where it ranks

Overall rank by patents

#1,295

of 49,997 tracked assignees

Innovation Score

53.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Bayer Pharma Aktiengesellschaft's patent record in context - here's where to go next.

Bayer Pharma Aktiengesellschaft's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 88.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #1,295 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bayer Pharma Aktiengesellschaft against Alpha and Omega Semiconductor, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.